The human colorectal carcinoma (CRC)-associated Ag CO17-1A/GA733, originally defined by mAbs CO17-1A and GA733, has been a useful target in passive immunotherapy of CRC patients with mAb and in active immunotherapy with anti-idiotypic Abs mimicking the CO17-1A or GA733 epitope. Both approaches have targeted single epitopes. We investigated the capacity of full-length CO17-1A/GA733 Ag expressing multiple potentially immunogenic epitopes and encoded by recombinant adenovirus 5 (Ad5 GA733-2) to induce humoral, cellular, and/or protective immunity in mice. Ad5 GA733-2 induced Ag-specific Abs that reacted predominantly to CO17-1A- and GA733-unrelated epitopes on the Ag and lysed Ag-positive CRC targets in conjunction with effector cells. Ad5 GA733-2-immune mice developed Ag-specific, proliferative lymphocytes of Th1 type and cytolytic lymphocytes. The use of Ad5 GA733-2 to immunize mice bearing established syngeneic CRC cells transfected with the human Ag induced significant and specific tumor regression. Cured mice resisted rechallenge with human CO17-1A/GA733 Ag-negative parental CRC cells, suggesting that targeting the human Ag on the murine transfectants induced protective immunity to other Ag expressed by the parental tumor. These results may explain the high potency of the recombinant vaccine. Thus, rAd5 GA733-2 may have potential as a vaccine for CRC patients.

The Wistar Institute Philadelphia PA 19104 USA

Literatura

000      

00000naa a2200000 a 4500

001      

bmc14041805

003      

CZ-PrNML

005      

20140313084821.0

007      

ta

008      

140113s1997 xxud f 000 0|eng||

009      

AR

035    __

$a (PubMed)9218593

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Li, Weiping $u The Wistar Institute, Philadelphia, PA 19104, USA

245    10

$a Human colorectal cancer (CRC) antigen CO17-1A/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice / $c W Li, K Berencsi, S Basak, R Somasundaram, RP Ricciardi, E Gonczol, J Zaloudik, A Linnenbach, H Maruyama, P Miniou, D Herlyn

504    __

$a Literatura

520    9_

$a The human colorectal carcinoma (CRC)-associated Ag CO17-1A/GA733, originally defined by mAbs CO17-1A and GA733, has been a useful target in passive immunotherapy of CRC patients with mAb and in active immunotherapy with anti-idiotypic Abs mimicking the CO17-1A or GA733 epitope. Both approaches have targeted single epitopes. We investigated the capacity of full-length CO17-1A/GA733 Ag expressing multiple potentially immunogenic epitopes and encoded by recombinant adenovirus 5 (Ad5 GA733-2) to induce humoral, cellular, and/or protective immunity in mice. Ad5 GA733-2 induced Ag-specific Abs that reacted predominantly to CO17-1A- and GA733-unrelated epitopes on the Ag and lysed Ag-positive CRC targets in conjunction with effector cells. Ad5 GA733-2-immune mice developed Ag-specific, proliferative lymphocytes of Th1 type and cytolytic lymphocytes. The use of Ad5 GA733-2 to immunize mice bearing established syngeneic CRC cells transfected with the human Ag induced significant and specific tumor regression. Cured mice resisted rechallenge with human CO17-1A/GA733 Ag-negative parental CRC cells, suggesting that targeting the human Ag on the murine transfectants induced protective immunity to other Ag expressed by the parental tumor. These results may explain the high potency of the recombinant vaccine. Thus, rAd5 GA733-2 may have potential as a vaccine for CRC patients.

536    __

$c Grant Number: CA 10815 (United States NCI NIH HHS)

536    __

$c Grant Number: CA 60595 (United States NCI NIH HHS)

536    __

$c Grant Number: CA29797 (United States NCI NIH HHS)

590    __

$a bohemika - dle Pubmed

650    12

$a Adenoviridae $x imunologie $7 D000256

650    02

$a zvířata $7 D000818

650    12

$a antigeny nádorové $x genetika $x imunologie $7 D000951

650    02

$a antigeny virové $x genetika $x imunologie $7 D000956

650    02

$a karcinom $x genetika $x imunologie $x patologie $7 D002277

650    02

$a buněčné dělení $x genetika $x imunologie $7 D002455

650    02

$a kolorektální nádory $x genetika $x imunologie $x patologie $7 D015179

650    12

$a regulace genové exprese u nádorů $x imunologie $7 D015972

650    02

$a lidé $7 D006801

650    02

$a myši $7 D051379

650    02

$a myši inbrední BALB C $7 D008807

650    02

$a experimentální nádory $x genetika $7 D009374

650    12

$a Neoplasms, Experimental $x im [Immunology]

650    02

$a Neoplasms, Experimental $x pa [Pathology]

655    _2

$a práce podpořená grantem $7 D013485

655    _2

$a Research Support, U.S. Gov't, P.H.S. $7 D013487

700    1_

$a Berencsi, Klara

700    1_

$a Basak, Saroj

700    1_

$a Somasundaram, Rajasekharan

700    1_

$a Ricciardi, Robert P.

700    1_

$a Gönczöl, Eva

700    1_

$a Žaloudík, Jan, $d 1954- $7 nlk20000083399

700    1_

$a Linnenbach, Alban

700    1_

$a Maruyama, Haruhiko

700    1_

$a Miniou, Pierre

700    1_

$a Herlyn, Dorothee $u The Wistar Institute, Philadelphia, PA 19104, USA

773    0_

$t The journal of immunology $x 0022-1767 $g Roč. 159, č. 2 (1997), s. 763-769 $p J Immunol $w MED00002741

773    0_

$p J Immunol $g 159(2):763-9, 1997 Jul 15 $x 0022-1767

910    __

$a ABA008 $b B 453 $y z $z 0

990    __

$a 20140113093615 $b ABA008

991    __

$a 20140313084830 $b ABA008

999    __

$a ok $b bmc $g 1006426 $s 840323

BAS    __

$a 3

BMC    __

$a 1997 $b 159 $c 2 $d 763-769 $x MED00002741 $i 0022-1767 $m The Journal of immunology $n J Immunol

GRA    __

$a IZ2923 $p MZ0

LZP    __

$a 2014-01/gvbo